{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:13:25Z","timestamp":1777857205845,"version":"3.51.4"},"reference-count":36,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JND"],"published-print":{"date-parts":[[2015,6,4]]},"DOI":"10.3233\/jnd-150081","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T05:23:24Z","timestamp":1432877004000},"page":"119-130","source":"Crossref","is-referenced-by-count":15,"title":["Spinal Muscular Atrophy Biomarker Measurements from Blood Samples in a Clinical Trial of Valproic Acid in Ambulatory Adults"],"prefix":"10.1177","volume":"2","author":[{"given":"Samantha R.","family":"Renusch","sequence":"first","affiliation":[{"name":"Department of Molecular & Cellular Biochemistry, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Harshman","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyang","family":"Pi","sequence":"additional","affiliation":[{"name":"Department of Molecular & Cellular Biochemistry, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen","family":"Workman","sequence":"additional","affiliation":[{"name":"Department of Molecular & Cellular Biochemistry, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Wehr","sequence":"additional","affiliation":[{"name":"Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobai","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W.","family":"Prior","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bakri H.","family":"Elsheikh","sequence":"additional","affiliation":[{"name":"Department of Neurology, Dhahran Medical Center, Dhahran, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn J.","family":"Swoboda","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Utah School of Medicine, Salt Lake City, Utah, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise R.","family":"Simard","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"Kissel","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Battle","sequence":"additional","affiliation":[{"name":"Department of Molecular & Cellular Biochemistry, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Parthun","sequence":"additional","affiliation":[{"name":"Department of Molecular & Cellular Biochemistry, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Freitas","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Kolb","sequence":"additional","affiliation":[{"name":"Department of Molecular & Cellular Biochemistry, The Ohio State University Wexner Medical Center, Columbus, OH, USA"},{"name":"Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"8","key":"10.3233\/JND-150081_ref1","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneurol.2011.74","article-title":"Spinal muscular atrophy: A timely review","volume":"68","author":"Kolb","year":"2011","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.3233\/JND-150081_ref2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"issue":"11","key":"10.3233\/JND-150081_ref3","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"Lorson","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"10.3233\/JND-150081_ref4","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","article-title":"A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2","volume":"8","author":"Monani","year":"1999","journal-title":"Human Molecular Genetics"},{"issue":"4","key":"10.3233\/JND-150081_ref5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ng1207","article-title":"A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy","volume":"34","author":"Kashima","year":"2003","journal-title":"Nature Genetics"},{"issue":"1","key":"10.3233\/JND-150081_ref6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00125817-200201000-00004","article-title":"Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2","volume":"4","author":"Mailman","year":"2002","journal-title":"Genet Med"},{"issue":"3","key":"10.3233\/JND-150081_ref7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","article-title":"The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-\/-) mice and results in a mouse with spinal muscular atrophy","volume":"9","author":"Monani","year":"2000","journal-title":"Human Molecular Genetics"},{"issue":"7","key":"10.3233\/JND-150081_ref8","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1212\/01.wnl.0000201929.56928.13","article-title":"SMN mRNA and protein levels in peripheral blood: Biomarkers for SMA clinical trials","volume":"66","author":"Sumner","year":"2006","journal-title":"Neurology"},{"issue":"19","key":"10.3233\/JND-150081_ref9","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","article-title":"Valproic acid increases the SMN2 protein level: A well-known drug as a potential therapy for spinal muscular atrophy","volume":"12","author":"Brichta","year":"2003","journal-title":"Human Molecular Genetics"},{"key":"10.3233\/JND-150081_ref10","first-page":"93","article-title":"Spliceosomal small nuclear ribonucleoprotein biogenesis defects and motor neuron selectivity in spinal muscular atrophy","author":"Workman","year":"1462","journal-title":"Brain Research"},{"issue":"5","key":"10.3233\/JND-150081_ref11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","article-title":"Valproic acid increases SMN levels in spinal muscular atrophy patient cells","volume":"54","author":"Sumner","year":"2003","journal-title":"Annals of Neurology"},{"issue":"9","key":"10.3233\/JND-150081_ref12","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/hmg\/ddi130","article-title":"The role of histone acetylation in SMN gene expression","volume":"14","author":"Kernochan","year":"2005","journal-title":"Human Molecular Genetics"},{"issue":"3","key":"10.3233\/JND-150081_ref13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.braindev.2011.04.010","article-title":"Valproic acid increases SMN2 expression and modulates SF2\/ASF and hnRNPA1 expression in SMA fibroblast cell lines","volume":"34","author":"Harahap","year":"2012","journal-title":"Brain & Development"},{"issue":"8","key":"10.3233\/JND-150081_ref14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1136\/jnnp.2009.200253","article-title":"Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: Effects of treatment with valproic acid","volume":"82","author":"Piepers","year":"2011","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"11","key":"10.3233\/JND-150081_ref15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00109-008-0388-1","article-title":"Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice","volume":"86","author":"Tsai","year":"2008","journal-title":"Journal of molecular medicine (Berlin, Germany)"},{"issue":"2","key":"10.3233\/JND-150081_ref16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/mus.23904","article-title":"SMA valiant trial: A prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy","volume":"49","author":"Kissel","year":"2014","journal-title":"Muscle & Nerve"},{"issue":"5","key":"10.3233\/JND-150081_ref17","doi-asserted-by":"crossref","first-page":"e5268","DOI":"10.1371\/journal.pone.0005268","article-title":"Phase II open label study of valproic acid in spinal muscular atrophy","volume":"4","author":"Swoboda","year":"2009","journal-title":"PloS One"},{"issue":"7","key":"10.3233\/JND-150081_ref18","doi-asserted-by":"crossref","first-page":"e21296","DOI":"10.1371\/journal.pone.0021296","article-title":"SMA CARNIVAL TRIAL PART II: A prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy","volume":"6","author":"Kissel","year":"2011","journal-title":"PloS One"},{"issue":"8","key":"10.3233\/JND-150081_ref19","doi-asserted-by":"crossref","first-page":"e12140","DOI":"10.1371\/journal.pone.0012140","article-title":"SMA CARNI-VAL trial part I: Double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy","volume":"5","author":"Swoboda","year":"2010","journal-title":"PloS One"},{"issue":"6","key":"10.3233\/JND-150081_ref20","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/ana.20836","article-title":"In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate","volume":"59","author":"Brichta","year":"2006","journal-title":"Ann Neurol"},{"issue":"2","key":"10.3233\/JND-150081_ref21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/hmg\/dds437","article-title":"VPA response in SMA is suppressed by the fatty acid translocase CD36","volume":"22","author":"Garbes","year":"2013","journal-title":"Human Molecular Genetics"},{"issue":"10","key":"10.3233\/JND-150081_ref22","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/ejhg.2011.89","article-title":"Treatment of spinal muscular atrophy cells with drugs that upregulate SMN expression reveals inter- and intra-patient variability","volume":"19","author":"Also-Rallo","year":"2011","journal-title":"European Journal of Human Genetics: EJHG"},{"issue":"6","key":"10.3233\/JND-150081_ref23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1212\/01.wnl.0000252934.70676.ab","article-title":"Preclinical validation of a multiplex real-time assay to quantify SMN mRNA in patients with SMA","volume":"68","author":"Simard","year":"2007","journal-title":"Neurology"},{"key":"10.3233\/JND-150081_ref24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2377-6-6","article-title":"A novel cell immunoassay to measure survival of motor neurons protein in blood cells","volume":"6","author":"Kolb","year":"2006","journal-title":"BMC Neurology"},{"issue":"10","key":"10.3233\/JND-150081_ref25","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.jasms.2005.06.001","article-title":"Peptide mass mapping of acetylated isoforms of histone H4 from mouse lymphosarcoma cells treated with histone deacetylase (HDACs) inhibitors","volume":"16","author":"Ren","year":"2005","journal-title":"Journal of the American Society for Mass Spectrometry"},{"issue":"23","key":"10.3233\/JND-150081_ref26","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1002\/pmic.201000080","article-title":"Assaying pharmacodynamic endpoints with targeted therapy: Flavopiridol and 17AAG induced dephosphorylation of histone H1.5 in acute myeloid leukemia","volume":"10","author":"Wang","year":"2010","journal-title":"Proteomics"},{"issue":"16","key":"10.3233\/JND-150081_ref27","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1002\/pmic.201000445","article-title":"High-sensitivity TFA-free LC-MS for profiling histones","volume":"11","author":"You","year":"2011","journal-title":"Proteomics"},{"issue":"1","key":"10.3233\/JND-150081_ref28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jasms.2003.10.001","article-title":"Differential expression of histone post-translational modifications in acute myeloid and chronic lymphocytic leukemia determined by high-pressure liquid chromatography and mass spectrometry","volume":"15","author":"Zhang","year":"2004","journal-title":"Journal of the American Society for Mass Spectrometry"},{"issue":"1","key":"10.3233\/JND-150081_ref29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ejhg.2009.116","article-title":"SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR","volume":"18","author":"Tiziano","year":"2010","journal-title":"European Journal of Human Genetics: EJHG"},{"issue":"13","key":"10.3233\/JND-150081_ref30","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1128\/MCB.25.13.5543-5551.2005","article-title":"The survival of motor neurons protein determines the capacity for snRNP assembly: Biochemical deficiency in spinal muscular atrophy","volume":"25","author":"Wan","year":"2005","journal-title":"Molecular and Cellular Biology"},{"issue":"6","key":"10.3233\/JND-150081_ref31","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1083\/jcb.138.6.1181","article-title":"Transportin-mediated nuclear import of heterogeneous nuclear RNP proteins","volume":"138","author":"Siomi","year":"1997","journal-title":"The Journal of Cell Biology"},{"issue":"3","key":"10.3233\/JND-150081_ref33","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1182\/blood-2004-05-1693","article-title":"A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia","volume":"105","author":"Byrd","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.3233\/JND-150081_ref34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1476-4598-4-22","article-title":"Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study","volume":"4","author":"Chavez-Blanco","year":"2005","journal-title":"Molecular Cancer"},{"issue":"5","key":"10.3233\/JND-150081_ref35","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/pmic.200800333","article-title":"Validation of an LC-MS based approach for profiling histones in chronic lymphocytic leukemia","volume":"9","author":"Su","year":"2009","journal-title":"Proteomics"},{"issue":"12","key":"10.3233\/JND-150081_ref36","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmg.2010.080366","article-title":"Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: Relevance for clinical trial design","volume":"47","author":"Tiziano","year":"2010","journal-title":"Journal of Medical Genetics"},{"issue":"11","key":"10.3233\/JND-150081_ref37","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.nmd.2014.05.013","article-title":"The influence of storage parameters on measurement of survival motor neuron (SMN) protein levels: Implications for pre-clinical studies and clinical trials for spinal muscular atrophy","volume":"24","author":"Hunter","year":"2014","journal-title":"Neuromuscular Disorders: NMD"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JND-150081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:52:56Z","timestamp":1777506776000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JND-150081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,4]]},"references-count":36,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jnd-150081","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,4]]}}}